127 related articles for article (PubMed ID: 10512753)
1. Critical amino acid substitutions in the Src SH3 domain that convert c-Src to be oncogenic.
Miyazaki K; Senga T; Matsuda S; Tanaka M; Machida K; Takenouchi Y; Nimura Y; Hamaguchi M
Biochem Biophys Res Commun; 1999 Oct; 263(3):759-64. PubMed ID: 10512753
[TBL] [Abstract][Full Text] [Related]
2. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
4. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
5. c-Src association with and phosphorylation of p58gag, a membrane- and microfilament-associated retroviral Gag-like protein in a xenotransplantable rat mammary tumor.
Huang J; Zhang BT; Li Y; Mayer B; Carraway KL; Carraway CA
Oncogene; 1999 Jul; 18(28):4099-107. PubMed ID: 10435591
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
Groysman M; Nagano M; Shaanan B; Katzav S
Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
[TBL] [Abstract][Full Text] [Related]
8. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
9. Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src.
Shen Z; Batzer A; Koehler JA; Polakis P; Schlessinger J; Lydon NB; Moran MF
Oncogene; 1999 Aug; 18(33):4647-53. PubMed ID: 10467411
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
12. The constitutive activation of the CEF-4/9E3 chemokine gene depends on C/EBPbeta in v-src transformed chicken embryo fibroblasts.
Gagliardi M; Maynard S; Bojovic B; Bédard PA
Oncogene; 2001 Apr; 20(18):2301-13. PubMed ID: 11402325
[TBL] [Abstract][Full Text] [Related]
13. Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.
Tatosyan A; Yatsula B; Shtutman M; Moinova E; Kaverina I; Musatkina E; Leskov K; Mizenina O; Zueva E; Calothy G; Dezélée P
Virology; 1996 Feb; 216(2):347-56. PubMed ID: 8607264
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic transformation by the FOX protein Qin requires DNA binding.
Ma Y; Geerdes DW; Vogt PK
Oncogene; 2000 Oct; 19(42):4815-21. PubMed ID: 11039897
[TBL] [Abstract][Full Text] [Related]
15. The role of backbone motions in ligand binding to the c-Src SH3 domain.
Wang C; Pawley NH; Nicholson LK
J Mol Biol; 2001 Nov; 313(4):873-87. PubMed ID: 11697910
[TBL] [Abstract][Full Text] [Related]
16. Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells.
Donaldson JC; Dempsey PJ; Reddy S; Bouton AH; Coffey RJ; Hanks SK
Exp Cell Res; 2000 Apr; 256(1):168-78. PubMed ID: 10739664
[TBL] [Abstract][Full Text] [Related]
17. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional motifs of the Rous sarcoma virus src protein.
Parsons JT; Wilkerson V; Parsons SJ
Gene Amplif Anal; 1986; 4():1-19. PubMed ID: 2851527
[TBL] [Abstract][Full Text] [Related]
19. Differential binding of pp60c-src and pp60v-src to cytoskeleton is mediated by SH2 and catalytic domains.
Okamura H; Resh MD
Oncogene; 1994 Aug; 9(8):2293-303. PubMed ID: 7518578
[TBL] [Abstract][Full Text] [Related]
20. Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.
Senga T; Miyazaki K; Machida K; Iwata H; Matsuda S; Nakashima I; Hamaguchi M
Oncogene; 2000 Jan; 19(2):273-9. PubMed ID: 10645006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
